Literature DB >> 9800249

Neurovascular applications of CT angiography.

B S Kuszyk1, N J Beauchamp, E K Fishman.   

Abstract

CT angiography, which has important advantages over both MR and ultrasound, is rapidly becoming an important modality for noninvasive evaluation of the neurovasculature. This article discusses CT angiography techniques for imaging the neurovasculature, including spiral acquisition protocols and image processing techniques, with a focus on the use of volume rendering for three-dimensional visualization. The clinical results for CT angiography of the cervical carotid arteries, intracranial aneurysms, arteriovenous malformations, and emerging work in the evaluation of acute stroke are reviewed. Important areas of ongoing research also are described.

Entities:  

Mesh:

Year:  1998        PMID: 9800249     DOI: 10.1016/s0887-2171(98)90016-6

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  4 in total

1.  Vascular compression by a ventricular shunt catheter: clinical value of volume-rendered CT angiography.

Authors:  P Gailloud; N J Beauchamp; J S Carpenter; S Albayram; K J Murphy
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Attenuation values of the intracranial arterial and venous vessels by bolus injection of various contrast agents: a study with a single-detector helical CT scanner.

Authors:  Morio Nagahata; Yoshinao Abe; Shuichi Ono; Hikaru Yamaguchi; Hiroyuki Miura; Takashi Ohata; Fumiyasu Tsushima; Kohei Morimoto; Hiroko Seino
Journal:  Radiat Med       Date:  2007-04-27

3.  Study of an adaptive bolus chasing CT angiography.

Authors:  Er-Wei Bai; James R Bennett; Robert McCabe; Melhem J Sharafuddin; Henri Bai; John Halloran; Michael Vannier; Ying Liu; Chenglin Wang; Ge Wang
Journal:  J Xray Sci Technol       Date:  2006       Impact factor: 1.535

4.  Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.

Authors:  Jing Wang; Shuzhi Wu; Tianren Huang
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.